Validation of 2-year 123I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure
Kenichi Nakajima(Kanazawa University), Arnold F. Jacobson(Leiden University), Takahisa Yamada(Osaka Prefectural Medical Center), Shinro Matsuo(Shiga University of Medical Science), Tetsuo Konno(Kanazawa University), Takahiro Doi(Fujieda Municipal General Hospital), Tomoaki Nakata(Hakodate National Hospital), Toshiaki Kadokami(Fukui-ken Saiseikai Hospital)
Cited by 24
Related Papers
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
|Journal of Clinical Investigation|2010|440
T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity
|Clinical Science|2003|313
T‐peak to T‐end interval may be a better predictor of high‐risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin i mutation than qt dispersion
|Clinical Cardiology|2002|267
KCNJ15/Kir4.2 couples with polyamines to sense weak extracellular electric fields in galvanotaxis
|Nature Communications|2015|124